about
Assessment of Critical Care Provider's Application of Preventive Measures for Ventilator-Associated Pneumonia in Intensive Care Units.Administration of lidocaine to prevent cognitive deficit in patients undergoing coronary artery bypass grafting and valve plasty: a systematic review and meta-analysis.Effect of Etomidate Versus Combination of Propofol-Ketamine and Thiopental-Ketamine on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double Blind Clinical Trial.Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial.Does lidocaine as an adjuvant to morphine improve pain relief in patients presenting to the ED with acute renal colic? A double-blind, randomized controlled trial.The effects of foot reflexology massage on anxiety in patients following coronary artery bypass graft surgery: a randomized controlled trial.The impact of oral care on oral health status and prevention of ventilator-associated pneumonia in critically ill patients.A double-blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibrillation after coronary artery bypass graft surgery.Pilonidal Sinus Operations Performed Under Local Anesthesia versus the General Anesthesia: Clinical Trial Study.Does Early Post-operative Administration of Aspirin Influence the Risk of Bleeding After Coronary Artery Bypass Graft Surgery? A Prospective Observational StudySleep quality and its correlation with serum C-reactive protein level in hemodialysis patients.Can Valeriana officinalis root extract prevent early postoperative cognitive dysfunction after CABG surgery? A randomized, double-blind, placebo-controlled trial.
P50
Q36077339-AC0F2CC3-5376-4485-A3A1-79DFC4E00871Q36205215-B2754758-8ECC-45B0-A83A-191B8D831B4CQ36806021-2FDFE4E8-DF63-4D4D-9FB3-CB7F5EBCF1B9Q39166867-3DA73D94-5512-4FC1-AC50-2472747E0942Q39178823-7E2299B3-5FE7-40BE-975B-718151C52F3DQ39213313-DA2B6EB6-99D3-42DF-8798-23BF696128CDQ40585021-581EB11F-4F48-4313-94D4-303D9A86B8A3Q40735807-460213E8-B2EF-4C99-9822-E8F29E7128E6Q41460496-4390DFDD-2D9D-496B-A60D-D1438A42BB0AQ41764487-D9254E08-1751-4A09-A51C-8DA46FC1126FQ48097567-91CD4EDA-70A7-4DD2-9C36-D37558D19276Q48573654-23F6B354-C0A2-4372-9848-D45C63250EF6
P50
description
investigador
@es
researcher
@en
name
Afshin Gholipour Baradari
@en
type
label
Afshin Gholipour Baradari
@en
prefLabel
Afshin Gholipour Baradari
@en
P31
P496
0000-0003-2316-1838